Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0002043411-26-000002

Chief Strategy Officer acquired 4,700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cioffi Christiana Marie Chief Strategy Officer 2026-03-26 Option exercise +4,700 $4.23 $19,881 4,700 D
Derivatives
Cioffi Christiana Marie Chief Strategy Officer 2026-03-26 Option exercise · Stock Options −4,700 $4.23 $19,881 145,300 D
Loading xslF345X06/form4-03262026_080303.xml…